Catalent, Inc. to Present at November 2020 Virtual Investor Conferences
11 November 2020 - 3:16PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that members of its
executive leadership team will present at two upcoming virtual
investor conferences.
On November 16, 2020 at 10:00 a.m. ET, the Company will present
at the Stephens Annual Investment Conference. On November 17, 2020
at 10:50 a.m. ET, the Company will present at the Jefferies London
Healthcare Conference.
A live webcast of both presentations will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the
leading global provider of advanced delivery technologies,
development, and manufacturing solutions for drugs, biologics, cell
and gene therapies, and consumer health products. With over 85
years serving the industry, Catalent has proven expertise in
bringing more customer products to market faster, enhancing product
performance and ensuring reliable clinical and commercial product
supply. Catalent employs more than 14,000 people, including
approximately 2,400 scientists, at more than 40 facilities across
four continents and in fiscal 2020 generated over $3 billion in
annual revenue. Catalent is headquartered in Somerset, N.J. For
more information, please visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201111005523/en/
Investors: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024